Skip to main content
. 2022 Jul 11;107(11-12):537–544. doi: 10.1159/000525627

Fig. 3.

Fig. 3

Results of the Bayesian network meta-analysis of randomized controlled studies assessing the relative efficacy (ASAS20) of JAK inhibitors and secukinumab.